Bruker Q3 Revenue $874M, Non-GAAP EPS $0.56 Up 24%; FY26 Guidance Reconfirmed
BRKR sits 74% above its 52-week low of $32.365 on elevated volume (2.0× avg).
Summary
Bruker reported Q3 2026 revenue of $874.0M (+1.6% yoy) and non-GAAP EPS of $0.56 (+24.4%), with a $174.5M non-cash goodwill impairment driving the GAAP loss. FY26 non-GAAP EPS guidance of $2.10-$2.15 was reconfirmed.
Key Events · Earnings and Guidance · BRKR
-
Q3 Revenue Up 1.6% to $874.0M
Revenue rose to $874.0M from $860.5M, with organic growth of 0.7%, acquisitions adding 1.7% and currency a 0.8% drag. BEST grew 11.2% while BSI organic revenue slipped 0.4%.
-
Non-GAAP Margin Jumps 400 bps
Non-GAAP operating income was $142.6M and margin 16.3% versus 12.3% a year ago; non-GAAP diluted EPS rose 24.4% to $0.56 from $0.45.
-
$174.5M Goodwill Impairment Drives GAAP Loss
GAAP operating loss was $(91.0)M and diluted loss per share $(0.81), driven by $174.5M of non-cash goodwill impairment charges; nine-month impairment charges total $309.4M.
-
FY26 EPS Guidance Reconfirmed
FY26 revenue guidance is $3.52-$3.56B (2.5%-3.5% reported growth, 1%-2% organic) with currency now neutral versus a prior 0.5% tailwind; non-GAAP EPS of $2.10-$2.15 is unchanged, up 15%-17% yoy.
Analysis · BRKR · Industrial Applications And Services
The headline number looks ugly, but Bruker's operating story is improving: revenue rose 1.6% to $874.0M and non-GAAP operating margin jumped 400 bps to 16.3%, lifting non-GAAP EPS 24.4% to $0.56. The GAAP loss of $(0.81) per share stems from a $174.5M non-cash goodwill impairment, not cash deterioration — free cash flow was $96.7M for the quarter versus negative $54.1M a year ago. Management reconfirmed FY26 non-GAAP EPS of $2.10-$2.15 and 1%-2% organic growth, but trimmed the currency tailwind to neutral from 0.5%, nudging the revenue range to $3.52-$3.56B. The key forward claim is a fifth straight quarter of BSI book-to-bill above one and mid-single-digit organic bookings and backlog growth year-to-date, which underpins management's expectation of revenue acceleration and double-digit EPS growth in FY27.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRKR was trading at $56.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.6B. The 52-week trading range was $32.37 to $66.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.